The physiology of lipoproteins
- PMID: 12466789
- DOI: 10.1067/mnc.2002.128959
The physiology of lipoproteins
Abstract
The seminal studies of Brown and Goldstein (Science 1986;232:34-47) coupled with the findings of the Framingham study revolutionized our understanding of the metabolic basis for vascular disease. These studies led to the widespread use of the coronary risk lipid profile, which uses the total cholesterol/high-density lipoprotein (HDL) ratio (or low-density lipoprotein [LDL]/HDL ratio) in predicting risk for vascular disease and as a tool for therapeutic management of patients at risk for vascular disease. However, although these methods are predictive of coronary artery disease (CAD) in general, it is also well known that the extent of occlusive disease and CAD varies greatly between individuals with similar cholesterol and HDL lipid profiles. For this reason, the National Cholesterol Education Program Expert Panel revised these guidelines and now recommends monitoring LDL and HDL cholesterol in the context of coronary heart disease risk factors and "risk equivalents." In addition, more recent findings indicate that specific alterations in individual lipoprotein subclasses may account for the variations in CAD in subjects with similar lipid profiles. For example, a preponderance of small, dense LDL particles correlates with a marked increase in risk for myocardial infarction independent of LDL levels. In particular, the association of small, dense LDL with elevated triglycerides (large, less dense VLDL) and reduced HDL has been defined as the atherogenic lipoprotein profile, and the key metabolic defect driving this profile may be elevated levels of triglycerides, specifically large, less dense VLDL. In an attempt to explain the physiologic basis for lipoprotein variations, this review describes the basic metabolic scheme underlying the traditional view of lipoprotein metabolism and physiology. It then examines the identity and role of the various lipoprotein subfractions in an attempt to distill a working model of how lipoprotein abnormalities might account for vascular disease in general and the metabolic syndrome in particular.
Similar articles
-
HDL subfractions analysis: a new laboratory diagnostic assay for patients with cardiovascular diseases and dyslipoproteinemia.Neuro Endocrinol Lett. 2011;32(4):502-9. Neuro Endocrinol Lett. 2011. PMID: 21876506 Clinical Trial.
-
Lipoprotein profile in patients who survive a stroke.Neuro Endocrinol Lett. 2011;32(4):496-501. Neuro Endocrinol Lett. 2011. PMID: 21876499
-
Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia.Metabolism. 2008 Jun;57(6):796-801. doi: 10.1016/j.metabol.2008.01.026. Metabolism. 2008. PMID: 18502262 Clinical Trial.
-
Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity.Am J Cardiol. 2002 Oct 17;90(8A):30i-47i. doi: 10.1016/s0002-9149(02)02749-2. Am J Cardiol. 2002. PMID: 12419479 Review.
-
Diabetic dyslipidemia.Am J Cardiol. 1998 Dec 17;82(12A):67U-73U; discussion 85U-86U. doi: 10.1016/s0002-9149(98)00848-0. Am J Cardiol. 1998. PMID: 9915665 Review.
Cited by
-
NAFLD and AATD Are Two Diseases with Unbalanced Lipid Metabolism: Similarities and Differences.Biomedicines. 2023 Jul 12;11(7):1961. doi: 10.3390/biomedicines11071961. Biomedicines. 2023. PMID: 37509601 Free PMC article. Review.
-
The Multiscale Dynamics of Beat-to-Beat Blood Pressure Fluctuation Links to Functions in Older Adults.Front Cardiovasc Med. 2022 Feb 23;9:833125. doi: 10.3389/fcvm.2022.833125. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35295251 Free PMC article.
-
Association of Breastfeeding Duration with 12-Month Postpartum Blood Lipids in a Predominately Lower-Income Hispanic Pregnancy Cohort in Los Angeles.Int J Environ Res Public Health. 2022 Mar 4;19(5):3008. doi: 10.3390/ijerph19053008. Int J Environ Res Public Health. 2022. PMID: 35270701 Free PMC article.
-
Comparison of nonfasting and fasting lipoprotein subfractions and size in 15,397 apparently healthy individuals: An analysis from the VITamin D and OmegA-3 TriaL.J Clin Lipidol. 2020 Mar-Apr;14(2):241-251. doi: 10.1016/j.jacl.2020.02.005. Epub 2020 Feb 21. J Clin Lipidol. 2020. PMID: 32205068 Free PMC article.
-
Does glucocorticoid exposure explain the association between metabolic dysfunction and tendinopathy?Endocr Connect. 2020 Jan 1;9(3):R36-46. doi: 10.1530/EC-19-0555. Online ahead of print. Endocr Connect. 2020. PMID: 31967969 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous